5-fluorouracil/leucovorin-induced inhibition of thymidylate synthase in normal tissues of mouse and man

Journal of Cancer Research and Clinical Oncology

Volumn 123, Issue 11-12, 1997, Pages 595-601

  Van Der Wilt, Clasina L ^a   Van Groeningen, Cornelis J ^a   Pinedo, Herbert M ^a   Smid, Kees ^a   Hoekman, Klaas ^a   Meijer, Sybren ^a   Peters, Godefridus J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

5 Fluorouracil; Colon cancer; Leucovorin; Thymidylate synthase

Indexed keywords

FLUOROURACIL; FOLINIC ACID; THYMIDYLATE SYNTHASE;

ARTICLE; BONE MARROW; COLON CANCER; COLON MUCOSA; CYTOTOXICITY; DOSE RESPONSE; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; LIVER; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; BONE MARROW; COLON; FEMALE; FLUOROURACIL; HUMANS; INTESTINAL MUCOSA; LEUCOVORIN; LIVER; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; THYMIDYLATE SYNTHASE; TIME FACTORS;

EID: 0031440039     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050111     Document Type: Article

References (24)

1. Bagrij T, Kralovanski J, Gyergyay F, Kiss E, Peters GJ (1993) Influence of uridine treatment in mice on the protection of gastrointestinal toxicity caused by 5-fluorouracil. Anticancer Res 13:789-794
2. Chu E, Koeller DM, Casey JL, Drake J, Chabner BA, Elwood PC, Zinn S, Allegra CJ (1991) Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc Natl Acad Sci USA 88:8977-8981
3. Danenberg PV (1977) Thymidylate synthetase - a target enzyme in cancer chemotherapy. Biochim Biophys Acta 473:73-92
4. De Bruijn EA, Remeyer L, Tjaden UR, Erkelens C, De Brauw LM, Van de Velde CJH (1986) Non-linear pharmacokinetics of 5-fluorouracil as described by in vivo behaviour of 5,6-dihydro5-fluorouracil. Biochem Pharmacol 35:2461-2465
5. 1 mice. Cancer Treat Rep 62:533-545
6. Houghton JA, Houghton PJ, Wooten RS (1979) Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2′-deoxyuridine. Cancer Res 39:2406-2413
7. Leichman CG (1994) Prolonged infusion of fluorinated pyrimidines in gastrointestinal malignancies: a review of recent clinical trials. Cancer Invest 12:166-175
8. Martin DS, Stolfi RL, Sawyer RC, Young CW (1982) High dose 5-fluorouracil with delayed uridine "rescue" in mice. Cancer Res 42:3964-3970
9. Nadal JC, Van Groeningen CJ, Pinedo HM, Peters GJ (1988) In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma. Biomed Pharmacother 42:387-393
10. Nadal JC, Van Groeningen CJ, Pinedo HM, Peters GJ (1989) Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma. Invest New Drugs 7:163-172
11. Nord LD, Stolfi RL, Martin DS (1992) Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue. Biochem Pharmacol 43:2543-2549
12. Peters GJ, Van Groeningen CJ (1991) Clinical relevance of biochemical modulation of 5-fluorouracil. Ann Oncol 2:469-480
13. Peters GJ, Van Dijk J, Nadal JC, Van Groeningen CJ, Lankelma J, Pinedo HM (1987) Diurnal variation in the therapeutic efficacy of 5 fluorouracil against murine colon cancer. In Vivo 1:113-118
14. Peters GJ, Van Dijk J, Laurensse E, Van Groeningen CJ, Leyva A, Nadal JC, Pinedo HM (1988) In vitro biochemical and in vivo biological studies of uridine "rescue" of 5-fluorouracil. Br J Cancer 57:259-265
15. Peters GJ, Van Groeningen C, Laurensse EJ, Pinedo HM (1991) Thymidylate synthase from untreated human colorectal cancer and colonic mucosa: enzyme activity and inhibition by 5-fluoro2′-deoxyuridine-5′-monophosphate. Eur J Cancer 27:263-267
16. Peters GJ, Lankelma J, Kok RM, Noordhuis P, Van Groeningen CJ, Van der wilt CL, Meyer S, Pinedo HM (1993) Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma. Cancer Chemother Pharmacol 31:269-276
17. Peters GJ, Van der wilt CL, van Groeningen C, Smid K, Meyer S, Pinedo HM (1994) Thymidylate synthase inhibition after administration of 5-fluorouracil with or without leucovorin in colon cancer patients; implications for treatment. J Clin Oncol 12:2035-2042
18. Piedbois P, Buyse M, Rustum Y, Machover D, Erlichman C, Carlson RW, et al (1992) Modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer evidence in terms of response rate. J Clin Oncol 10:896-903
19. Steinberg SE, Campell CL, Hillman RS (1979) Kinetics of the normal folate enterohepatic cycle. J Clin Invest 64:83-88
20. Swain SM, Lippman ME, Egan EF, Drake JC, Steinberg SM, Allegra CJ (1989) Fluorouracil and high dose leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 7:890-899
21. Van Groeningen CJ, Peters GJ, Leyva A, Laurensse EJ, Pinedo HM (1989) Reversal of 5-fluorouracil-induced myelosuppression by prolonged administration of high-dose uridine. J Natl Cancer Inst 81:157-162
22. Van Groeningen CJ, Peters GJ, Pinedo HM (1993) Reversal of 5-fluorouracil-induced toxicity by oral administration of uridine. Ann Oncol 4:317-320
23. Van der wilt CL, Pinedo HM, Smid K, Peters GJ (1992) Elevation of thymidylate synthase after 5-fluorouracil in murine tumors is prevented by the addition of folinic acid. Cancer Res 52:4922-4929
24. Van der wilt CL, Marinelli A, Pinedo HM, Cloos J, Smid K, Van de Velde CJH, Peters GJ (1995) The effect of different routes of administration of 5-fluorouracil on thymidylate synthase inhibition in the rat. Eur J Cancer 31a:754-760